HPV Vaccine KnowledgeNCT04766164
Health Beliefs, Behaviors, and Healthcare Experiences Among United States Young and Mid-Age Adults
An observational study of HPV Vaccine Knowledge, run by H. Lee Moffitt Cancer Center and Research Institute at 1 site in United States.
Trial summary
The study will provide important insight into current HPV vaccine knowledge/awareness, health beliefs, affect, vaccine discussions, decision preparedness, and vaccine intentions and behaviors among those ages 18-45, while examining potential differences in responses between those ages 18-26 and those ages 27-45 and… Read more about this study
- Who is it for?
- Ages 18 to 45 years
- Conditions the study is for
- HPV Vaccine Knowledge
- What is being tested?
- Survey
- Type of treatment
- Lifestyle or therapy programme
- How many people
- 4,000 participants
- Where
- 1 siteUnited States
- Study dates
- 17 Feb 2021to 6 Jul 2022
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 45 years
- All sexes
- Adult
Study population: Participants living throughout the United States
Who may be able to join
- Age 18-45
- Living in the United States
- a KnowledgePanel panelist directly or via verified partners
- Have internet access
- Able to read, write and understand English
- Individuals can participant regardless of their HPV vaccination status
Who cannot join
- Individuals who do not meet inclusion criteria
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Health Beliefs, Behaviors, and Healthcare Experiences Among a National Sample of United States Young and Mid-Age Adults
The study will provide important insight into current HPV vaccine knowledge/awareness, health beliefs, affect, vaccine discussions, decision preparedness, and vaccine intentions and behaviors among those ages 18-45, while examining potential differences in responses between those ages 18-26 and those ages 27-45 and vaccinated and unvaccinated individuals.
Read the detailed description
The study will provide important insight into current HPV vaccine knowledge/awareness, health beliefs, affect, vaccine discussions, decision preparedness, and vaccine intentions and behaviors among those ages 18-45, while examining potential differences in responses between those ages 18-26 and those ages 27-45 and vaccinated and unvaccinated individuals. In addition, the study will illuminate gaps in knowledge and awareness as well as the education intervention preferences (e.g., intervention platform, source of information, timing of intervention) of individuals ages 18-45. Among those ages 27-45, shared clinical decision-making is recommended. Compared to individuals ages 18-26, individuals ages 27-45 may need to be supported uniquely so that they are prepared to engage in shared clinical decision-making about HPV vaccination with their healthcare provider. Thus, among unvaccinated individuals ages 27-45, for whom shared clinical decision-making is recommended, preparedness for engagement in shared clinical decision-making will be assessed and explored. The study also will allow investigators to identify how best to target information to young adults and mid-adults both for themselves, and among those with children, for their children.
- Conditions
- HPV Vaccine Knowledge
- Being tested
- Survey
- Keywords
- HPV, HPV Vaccine
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
SurveyBehavioural
Data will be obtained via self-report from participants via a one-time Qualtrics survey.
| Study group | Role | What they receive |
|---|---|---|
| Males and Females ages 18-26 | Participants between the ages of 18-26 will complete a survey Receives: Behavioral: Survey | |
| Males and Females ages 27-45 | Participants between the ages of 27-45 will complete a survey Receives: Behavioral: Survey |
What is being measured
The primary outcome is the main question the study is designed to answer.
HPV Vaccine Knowledge
Data from survey will describe HPV and HPV vaccine knowledge, health beliefs, attitudes, affect, health literacy, health care experiences, vaccine discussions and information sources, preparedness for shared decision-making and HPV vaccine uptake and intentions and examine relationships between these variables among a national sample of U.S. adults (N=4,000) ages 18-45 years.
Measured: Day 1
HPV-Related Educational Intervention Preferences
Data from survey will describe intervention preferences and associations between intervention preferences and sociodemographic variables (e.g., age, gender, race, ethnicity, socioeconomic status, employment status, parental status, and insurance status).
Measured: Day 1
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted23 Feb 2021
- Study start17 Feb 2021
- Primary completion6 Jul 2022
- Study completion6 Jul 2022
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for HPV Vaccine KnowledgeStudies of the same condition, open and under way.
- More trials run by H. Lee Moffitt Cancer Center and Research InstituteThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Cross-sectional
- Enrolment
- 4,000 participants (actual)
Sponsor and investigators
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Shannon M Christy, PhD, Principal investigator, Moffitt Cancer Center
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04766164
- Sponsor's protocol ID
- MCC-20853
- Status last verified
- Nov 2022
- First submitted
- 19 Feb 2021
- Last updated
- 3 Nov 2022
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 3 Nov 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Health Beliefs, Behaviors, and Healthcare Experiences Among a National Sample of United States Young and Mid-Age Adults
- ClinicalTrials.gov ID
- NCT04766164
- Acronym / sponsor ID
- MCC-20853
- Conditions
- HPV Vaccine Knowledge
- Keywords
- HPV, HPV Vaccine
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 4,000 participants (actual)
- Lead sponsor
- H. Lee Moffitt Cancer Center and Research InstituteUniversity, hospital or other
- Study start
- 17 Feb 2021 (actual)
- Primary completion
- 6 Jul 2022 (actual)
- Study completion
- 6 Jul 2022 (actual)
- First posted
- 23 Feb 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The study will provide important insight into current HPV vaccine knowledge/awareness, health beliefs, affect, vaccine discussions, decision preparedness, and vaccine intentions and behaviors among those ages 18-45, while examining potential differences in responses between those ages 18-26 and those ages 27-45 and vaccinated and unvaccinated individuals.
Detailed description
The study will provide important insight into current HPV vaccine knowledge/awareness, health beliefs, affect, vaccine discussions, decision preparedness, and vaccine intentions and behaviors among those ages 18-45, while examining potential differences in responses between those ages 18-26 and those ages 27-45 and vaccinated and unvaccinated individuals. In addition, the study will illuminate gaps in knowledge and awareness as well as the education intervention preferences (e.g., intervention platform, source of information, timing of intervention) of individuals ages 18-45. Among those ages 27-45, shared clinical decision-making is recommended. Compared to individuals ages 18-26, individuals ages 27-45 may need to be supported uniquely so that they are prepared to engage in shared clinical decision-making about HPV vaccination with their healthcare provider. Thus, among unvaccinated individuals ages 27-45, for whom shared clinical decision-making is recommended, preparedness for engagement in shared clinical decision-making will be assessed and explored. The study also will allow investigators to identify how best to target information to young adults and mid-adults both for themselves, and among those with children, for their children.
Study design
- Observational model
- Cohort
- Time perspective
- Cross-sectional
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Males and Females ages 18-26 | – | Behavioral: SurveyParticipants between the ages of 18-26 will complete a survey |
| Males and Females ages 27-45 | – | Behavioral: SurveyParticipants between the ages of 27-45 will complete a survey |
Who may qualify
- Ages
- 18 to 45 years
- Sex
- All
- Age groups
- Adult
- Study population
- Participants living throughout the United States
Key inclusion criteria (6 listed)
- Age 18-45
- Living in the United States
- a KnowledgePanel panelist directly or via verified partners
- Have internet access
- Able to read, write and understand English
Key exclusion criteria (1 listed)
- Individuals who do not meet inclusion criteria
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| SurveyData will be obtained via self-report from participants via a one-time Qualtrics survey. | Behavioural | Males and Females ages 18-26, Males and Females ages 27-45 |
Primary outcome
HPV Vaccine Knowledge
Time frame: Day 1
Data from survey will describe HPV and HPV vaccine knowledge, health beliefs, attitudes, affect, health literacy, health care experiences, vaccine discussions and information sources, preparedness for shared decision-making and HPV vaccine uptake and intentions and examine relationships between these variables among a national sample of U.S. adults (N=4,000) ages 18-45 years.
HPV-Related Educational Intervention Preferences
Time frame: Day 1
Data from survey will describe intervention preferences and associations between intervention preferences and sociodemographic variables (e.g., age, gender, race, ethnicity, socioeconomic status, employment status, parental status, and insurance status).
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 3 Nov 2022.
Related trials for HPV Vaccine Knowledge
Active, not recruitingPhase 3
PREVENT HPV -Related Cancers Trial
HPV Vaccination, Uptake Vaccination
Recruiting
The Effect of a Transtheoretical Model-Based Educational Intervention on First-Year Nursing Students' HPV Knowledge, Health Beliefs, and Vaccination Behavior Intentions
Human Papillomavirus (HPV), Papillomavirus Vaccines
Not yet recruiting
The Effect of the Health Belief Model-Based Education Given to Mothers of Children Aged 9-15 on HPV Knowledge Level and Child Vaccination
Cancer , Healthy, HPV - Anogenital Human Papilloma Virus Infection
Not yet recruiting
The Effect of Health Belief Model-Based Education and Motivational Interviewing on HPV (Human Papilloma Virus) Knowledge and Vaccine Awareness in Women
Human Papillomavirus Infection
Recruiting
Integration to Improve Adolescent Health and HPV Vaccination in Laos
Healthy, Adolescents
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Shannon M Christy, PhD principal investigator
Moffitt Cancer Center
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of HPV Vaccine Knowledge, run by H. Lee Moffitt Cancer Center and Research Institute at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 3 Nov 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
HPV Vaccine Knowledge (time frame: Day 1). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Nov 2022.